RANI Rani Therapeutics Holdings, Inc.: institutional ownership and insider trading
72 funds reported holding $44.5M of Rani Therapeutics Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $3.76M, with 10 new positions and 16 funds selling out; over the last 12 months insiders bought $50.0K and sold $301 on the open market; over its last four quarters it reported revenue of $4.88M and net income of −$30.1M.
RANI revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.71M, net income −$7.39M, EPS -0.04
- Quarter ended Mar 31, 2026: revenue $1.71M, net income −$7.03M, EPS -0.04
- Quarter ended Dec 31, 2025: revenue $1.46M, net income −$10.3M, EPS 0.07
- Quarter ended Sep 30, 2025: revenue $0, net income −$5.41M, EPS -0.12
Famous investors holding RANI
- Ken Griffin (Citadel Advisors): $500K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $328K, 0.0% of the portfolio
Largest institutional holders of RANI
- Samsara BioCapital, LLC — $7.88M
- VANGUARD GROUP INC — $6.90M
- RA CAPITAL MANAGEMENT, L.P. — $6.46M
- AWM Investment Company, Inc. — $5.70M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.47M
- SymBiosis Capital Partners, LLC — $2.69M
- Longaeva Partners L.P. — $1.77M
- Polar Asset Management Partners Inc. — $1.76M
- Siren, L.L.C. — $1.52M
- HEIGHTS CAPITAL MANAGEMENT, INC — $711K
Recent RANI insider trades
- Jul 21, 2026: Imran Mir A bought 36,000 shares ($24.8K)
- Jul 17, 2026: Imran Talat bought 35,000 shares ($25.2K)
- Mar 27, 2026: Javadi Alireza sold 386 shares ($301)
- Oct 23, 2025: Imran Mir A bought 2,083,334 shares ($1.27M)
5%+ owners
- RA Capital Management, L.P.: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
- Srinivas Akkaraju: 9.9% (Schedule 13D/A, filed May 28, 2026)
Who owns the most RANI stock?
The largest institutional holders of Rani Therapeutics Holdings, Inc. in the latest 13F filings are Samsara BioCapital, LLC ($7.88M), VANGUARD GROUP INC ($6.90M), RA CAPITAL MANAGEMENT, L.P. ($6.46M).
Are insiders buying or selling RANI?
Over the last 12 months insiders bought $50.0K and sold $301 of Rani Therapeutics Holdings, Inc. stock on the open market (SEC Form 4).
Which famous investors own RANI?
Ken Griffin, Renaissance Technologies.
What was RANI's revenue last quarter?
Rani Therapeutics Holdings, Inc. reported revenue of $1.71M for the quarter ended June 30, 2026, with net income of −$7.39M.